Many physicians empirically hold angiotensin-converting enzyme inhibitors before the administration of iodinated contrast. This prospective, single-center study, objectively quantifies the increased risk to contrast-induced nephropathy that patients would experience if they are exposed to angiotensin-converting enzyme inhibitors within 72 hours of exposure.

Time Required (estimated): 20 minutes
Title: Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors of AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) Trial
Citation: Nephrology Dialysis Transplantation 2010, Volume 25, pp. 759-64
Date Created: 2010
Revisions: None Indicated
Disclaimers: None Indicated
Resource Type: Text
Other: Recommended by Hitarth Dave, MS IV
Recommend to a Colleague/Friend

Was this teaching resource valuable? Scroll down and complete our 6-point Transparent Peer Evaluation.

Transparent Peer Review
Your reviews are anonymous

[starratingmulti id=”3″]

To learn more about our 6-point transparent peer review system, click here



You must be logged in to post a comment.




Speak your mind

  • Nephrology On-Demand Plus

    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


  • Kidney Konnection

    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription